Published in American Journal of Psychiatry · View the paper (DOI)
New research finds that low-dose buprenorphine given after a single ketamine infusion can sustain reductions in suicidal ideation in adults with major depressive disorder. The study showed a 76% reduction in suicidal ideation at week four, compared to a 43% reduction in the placebo group.
Coverage from 2 institutions